Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Dow
Medtronic
Johnson and Johnson
Moodys
Express Scripts

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

Zydus Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for ZYDUS, and what generic and branded alternatives to ZYDUS drugs are available?

ZYDUS has two hundred and sixteen approved drugs.

There are eighteen tentative approvals on ZYDUS drugs.

Summary for Zydus
US Patents:0
Tradenames:182
Ingredients:181
NDAs:216
Patent Litigation for Zydus: See patent lawsuits for Zydus

Drugs and US Patents for Zydus

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM amlodipine besylate; atorvastatin calcium TABLET;ORAL 207762-011 Jan 11, 2019 DISCN No No   Start Trial   Start Trial
Zydus Pharms CANDESARTAN CILEXETIL candesartan cilexetil TABLET;ORAL 091390-001 Aug 23, 2017 AB RX No No   Start Trial   Start Trial
Zydus Pharms Usa LAMOTRIGINE lamotrigine TABLET;ORAL 077633-004 Jan 27, 2009 AB RX No No   Start Trial   Start Trial
Zydus Pharms Usa RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 078516-003 May 1, 2009 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Mallinckrodt
Baxter
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.